Ezetimibe and simvastatin and Lomitapide interaction

Ezetimibe and simvastatin and Lomitapide: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Ezetimibe and simvastatin (VYTORIN) label · effective 2026-01-21

Moderate

VYTORIN dosage modifications are recommended for patients taking lomitapide, verapamil, diltiazem, dronedarone, amiodarone, amlodipine or ranolazine [see Dosage and Administration (2.5) ] .

Warnings and precautionsnames LomitapideView label on DailyMed
Moderate

Lomitapide Clinical Impact: Simvastatin exposure is approximately doubled with concomitant use of lomitapide and the risk of myopathy and rhabdomyolysis is increased.

Drug interactionsnames LomitapideView label on DailyMed
Moderate

Intervention: Reduce the dose of VYTORIN by 50% if initiating lomitapide.

Drug interactionsnames LomitapideView label on DailyMed
Moderate

Do not exceed VYTORIN 10/20 mg daily (or VYTORIN 10/40 mg daily for patients who have previously taken VYTORIN 10/80 mg daily chronically) while taking lomitapide [see Dosage and Administration (2.1 , 2.3) ] .

Drug interactionsnames LomitapideView label on DailyMed

From the Lomitapide (Juxtapid) label · effective 2026-01-20

Moderate

Risk of Myopathy with Concomitant Use of Simvastatin or Lovastatin The risk of myopathy, including rhabdomyolysis, with simvastatin and lovastatin monotherapy is dose related.

Warnings and precautionsnames Ezetimibe and simvastatinView label on DailyMed
Moderate

Lomitapide approximately doubles the exposure to simvastatin; therefore, it is recommended to reduce the dose of simvastatin by 50% when initiating JUXTAPID [see Clinical Pharmacology (12.3) ] .

Warnings and precautionsnames Ezetimibe and simvastatinView label on DailyMed
Moderate

While taking JUXTAPID, limit simvastatin dosage to 20 mg daily (or 40 mg daily for patients who have previously tolerated simvastatin 80 mg daily for at least one year without evidence of muscle toxicity).

Warnings and precautionsnames Ezetimibe and simvastatinView label on DailyMed
Moderate

However, the metabolizing enzymes and transporters responsible for the disposition of lovastatin and simvastatin are similar, suggesting that JUXTAPID may increase the exposure of lovastatin; therefore, reducing the dose of lovastatin should be considered when initiating JUXTAPID.

Warnings and precautionsnames Ezetimibe and simvastatinView label on DailyMed
Moderate

Simvastatin and lovastatin exposure increase with JUXTAPID.

Drug interactionsnames Ezetimibe and simvastatinView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.